Minnelide Overcomes Oxaliplatin Resistance by Downregulating DNA Repair Pathway in Pancreatic Cancer

INTRODUCTION: Oxaliplatin is part of pancreatic cancer therapy in FOLFIRINOX or GEMOX/XELOX regimen. DNA damage repair is one of the factors responsible for oxaliplatin resistance that eventually develops in this cancer. Triptolide/Minnelide has been shown to be effective against pancreatic cancer i...

Full description

Saved in:
Bibliographic Details
Published in:J Gastrointest Surg
Main Authors: Modi, Shrey, Kir, Devika, Giri, Bhuwan, Majumder, Kaustav, Arora, Nivedita, Dudeja, Vikas, Banerjee, Sulagna, Saluja, Ashok K
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698020/
https://ncbi.nlm.nih.gov/pubmed/26503259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-015-3000-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items